Cellular Biomedicine Group, Inc. Debt to Equity Ratio 2010-2020 | CBMG

Current and historical debt to equity ratio values for Cellular Biomedicine Group, Inc. (CBMG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cellular Biomedicine Group, Inc. debt/equity for the three months ending September 30, 2020 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2020-09-30 $0.08B $0.02B 4.37
2020-06-30 $0.05B $0.03B 1.38
2020-03-31 $0.04B $0.05B 0.90
2019-12-31 $0.04B $0.06B 0.75
2019-09-30 $0.04B $0.07B 0.57
2019-06-30 $0.04B $0.08B 0.43
2019-03-31 $0.03B $0.09B 0.31
2018-12-31 $0.02B $0.09B 0.26
2018-09-30 $0.01B $0.10B 0.06
2018-06-30 $0.01B $0.07B 0.07
2018-03-31 $0.01B $0.08B 0.07
2017-12-31 $0.00B $0.06B 0.07
2017-09-30 $0.00B $0.05B 0.08
2017-06-30 $0.01B $0.06B 0.08
2017-03-31 $0.00B $0.06B 0.04
2016-12-31 $0.00B $0.07B 0.04
2016-09-30 $0.00B $0.07B 0.03
2016-06-30 $0.00B $0.09B 0.03
2016-03-31 $0.01B $0.07B 0.10
2015-12-31 $0.00B $0.05B 0.07
2015-09-30 $0.01B $0.06B 0.09
2015-06-30 $0.01B $0.06B 0.09
2015-03-31 $0.01B $0.05B 0.10
2014-12-31 $0.01B $0.04B 0.12
2014-09-30 $0.01B $0.04B 0.15
2014-06-30 $0.00B $0.02B 0.11
2014-03-31 $0.00B $0.02B 0.11
2013-12-31 $0.00B $0.02B 0.14
2013-09-30 $0.00B $0.02B 0.13
2013-06-30 $0.00B $0.01B 0.23
2013-03-31 $0.00B $0.01B 0.24
2012-12-31 $0.00B $0.01B 0.10
2012-09-30 $0.01B $0.00B 2.09
2012-06-30 $0.00B $-0.00B -2.50
2012-03-31 $0.00B $-0.00B -3.35
2011-12-31 $0.00B $0.00B -4.63
2011-09-30 $0.00B $-0.00B -3.36
2011-06-30 $0.00B $0.00B -8.23
2011-03-31 $0.00B 0.00
2010-12-31 $0.00B 0.00
2010-09-30 $0.00B 0.00
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00